MLQ.ai | Stocks

Lucid Group (LCID) News

Price: $2.47
Market Cap: $7.49B
Avg Volume: 93.87M

Country: US
Industry: Auto - Manufacturers
Sector: Consumer Cyclical

Beta: 0.98
52W Range: $1.93-4.43
Website: Lucid Group

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Processed a record 4,042 EsoGuard tests in 4Q24, a 45% sequential and 84% annual increase Recognized EsoGuard revenue of $1.2 million in 4Q24 New sales channel generated over 20 new cash-pay concierge medicine contracts Secured first agreement to pay for EsoGuard under state biomarker legislation Conference call and webcast to be held today, March 24 th at 8:30 AM EDT NEW YORK , March 24, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today provided a business update for the Company and reported financial results for the fourth quarter and full year ended December 31, 2024. Conference Call and Webcast The webcast will take place on Monday, March 24, 2024, at 8:30 AM and will be accessible in the investor relations section of the Company's website at luciddx.com.

prnewswire.com

Think It's Too Late to Buy Lucid Group? Here's the Biggest Reason Why There's Still Time.

Typically, stocks expected to grow sales significantly in the year to come are priced at a premium. And to be sure, Lucid Group (LCID 5.92%) shares aren't necessarily cheap at 7.3 times sales.

fool.com

Is Lucid Group Stock a Buy Now?

Lucid Group (LCID 1.75%) is a premium electric vehicle (EV) manufacturer that has captured attention with its innovative automotive offerings. The company has made noteworthy advancements in EV technology, especially with the Lucid Air and the upcoming Lucid Gravity SUV.

fool.com

Lucid's Stock Comeback—Is a Long-Term Recovery Ahead?

Lucid Group, Inc. NASDAQ: LCID, a luxury electric vehicle (EV) manufacturer, has seen dramatic stock price fluctuations in recent months. After a prolonged period of volatility and decline, Lucid's stock started showing signs of a possible recovery before a sharp drop around Valentine's Day 2025.

marketbeat.com

Lucid Doubling Production Isn't Enough: Why the EV Maker's Financial Forecast Signals Risks Through 2026

Lucid Group (LCID -3.07%) is one of many electric vehicle (EV) start-ups trying to catch the lightning in a bottle that was Tesla. Given the increase in competition in the vehicle niche, investors have figured out that this is probably an unrealistic goal.

fool.com

Lucid stock trading volume hits 5-month high; Buy signal or false alarm?

Although its 2021 initial public offering (IPO) attracted plenty of attention, Lucid Motors has seen consistent struggles with profitability and production thus far.

finbold.com

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy NEW YORK , March 20, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that a recent update to the National Comprehensive Cancer Network ® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) focused on Esophageal and Esophagogastric Junction Cancers (Version 1.2025) has added a new section on esophageal precancer (Barrett's Esophagus or BE) screening. The NCCN Guidelines® now reference professional society guidelines on BE screening, including the most recent American College of Gastroenterology (ACG) Clinical Guideline which recommends non-endoscopic biomarker testing, such as Lucid's EsoGuard® Esophageal DNA Test performed on samples collected with its EsoCheck® Esophageal Cell Collection Device, as an acceptable alternative to invasive upper endoscopy to detect esophageal precancer.

prnewswire.com

If You'd Invested $1,000 in Lucid Stock 4 Years Ago, Here's How Much You'd Have Today

Lucid Group (LCID 9.26%) debuted on the Nasdaq stock exchange with much fanfare on July 26, 2021 after merging with a special purpose acquisition company (SPAC). The electric-vehicle (EV) stock jumped by double-digit percentages on the day of listing and hit an all-time high of $57.75 on Nov. 15, 2021.

fool.com

Market sell-off drags Dow, S&P 500 down; Tesla, Google dip and Lucid surges

After two straight trading days of gains, US stocks fell on Tuesday as the sell-off resumed once again. At the time of writing, the Dow Jones Industrial Average was down 0.5%, while the S&P 500 index slipped 1% from the previous close.

invezz.com

Why Lucid Motors Stock Soared Today

Lucid (LCID 12.96%) got an upgrade today, and the stock is soaring. However, overall, shares of the luxury electric vehicle (EV) maker aren't having a good start to the year.

fool.com

Analyst updates Lucid stock price target on AI integration

Despite the hype from the initial public offering (IPO) era and the backing of one of the richest entities in the world, the Saudi Arabian Public Investment Fund (PIF), Lucid (NASDAQ: LCID), hasn't exactly been eponymous with strong stock market performance.

finbold.com

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Study confirms clinical utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive upper endoscopy NEW YORK , March 18, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that its ENVET-BE clinical utility study has been accepted for publication in Gastroenterology & Hepatology —the fifth peer-reviewed publication of clinical utility data for Lucid's EsoGuard® Esophageal DNA Test, and the second to present findings from a real-world screening population. The manuscript, entitled Enhancing the Diagnostic Yield of EGD for Diagnosis of Barrett's Esophagus Through Methylated DNA Biomarker Triage , demonstrates that confirmatory upper endoscopy (EGD) performed in EsoGuard-positive patients had a substantially higher diagnostic yield for detecting esophageal precancer (Barrett's Esophagus or BE) than the expected yield of screening EGD alone in at-risk patients.

prnewswire.com

Lucid is looking for a new CEO. Why that may be a good thing.

Change afoot at Lucid might be a chance to play a bigger role in EVs and AI.

marketwatch.com

Is It Time to Buy the Dip on Lucid Group Stock?

Lucid Group (LCID 1.91%) stock experienced a hard correction in late February. In the middle of the month, shares traded as high as $3.50.

fool.com

Should Investors Buy Lucid Stock on the Dip?

Lucid (LCID 2.96%) forecasts that its vehicle deliveries will roughly double in 2025 as it ramps up production of its new SUV.

fool.com

2 Reasons Lucid Group Is a Long-Term Buy for 2030 and Beyond

It's difficult to buy great growth stocks at a discount. That's especially true when the market already expects rapid growth to occur in the near future.

fool.com

Prediction: Lucid Group Will Soar Over the Next 3 Years. Here's 1 Reason Why.

It's been a tough few weeks for electric vehicle (EV) stocks like Lucid Group (LCID -6.02%), with the company's shares suddenly losing nearly 40% of their value. Many high-growth businesses have seen their valuations shrink in 2025, and Lucid has been no exception.

fool.com

Why Lucid Stock Is Falling Today

Shares of the eclectic vehicle start-up Lucid Group (LCID -6.48%) fell today after the Trump administration said late yesterday that it would roll back requirements on automakers to produce electric vehicles (EVs).

fool.com

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

Regional Blue Cross Blue Shield plan will cover non-invasive screening of esophageal precancer and cancer NEW YORK , March 13, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that Highmark Blue Cross Blue Shield, an independent licensee of the Blue Cross and Blue Shield Association, has issued a positive coverage policy for non-invasive screening of esophageal precancer and cancer in New York state. The new policy will cover Lucid's EsoGuard® Esophageal DNA Test in patients who meet established criteria for esophageal precancer testing consistent with professional society guidelines.

prnewswire.com

Short squeeze alert for Lucid stock

Though Lucid's (NASDAQ: LCID) short volume ratio has remained relatively stable, if heightened, the stock's unexpected upsurge created conditions for a substantial short squeeze.

finbold.com

Lucid Group (LCID) Ascends While Market Falls: Some Facts to Note

The latest trading day saw Lucid Group (LCID) settling at $2.09, representing a +0.48% change from its previous close.

zacks.com

Every Lucid Group Investor Should Keep an Eye on This Number

Electric vehicle (EV) investors who have chosen to hitch a ride with Lucid Group (LCID -0.24%) have a lot of facts and figures to keep track of, from the number of vehicles produced to the number of vehicles delivered to all the data found in the financial statements.

fool.com

Why Lucid Stock Is Bucking the Market Trend Today

There's a lot of red in the market today. The Nasdaq Composite index dropped as much as 3% Monday morning, and the S&P 500 index was lower by almost 2%.

fool.com

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK , March 10, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Monday, March 24, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D.

prnewswire.com

Lucid's CEO Steps Down. Is the Stock a Sell?

You can't blame a Lucid Group (LCID 2.87%) investor for sighing loudly during the fourth-quarter conference call. After years of mostly disappointing investors with production hiccups, earnings misses, delays, and other developments, Lucid finally had real positive momentum in 2024.

fool.com

Here's Why Lucid Is Far Behind in the EV Race

Building a company from the ground up in a capital-intensive industry is difficult to do. It is even more difficult when that industry has a small number of large and entrenched leaders.

fool.com

Why Lucid Stock Skidded 19.6% in February and Keeps Falling Further

Shares of Lucid Group (LCID 1.68%) were losing momentum early in the year, but not many expected the stock to fall so much so soon. An unexpected turn of events sent the electric vehicle (EV) stock plunging 19.6% in February, according to data provided by S&P Global Market Intelligence.

fool.com

4 EV Stocks Facing Uncertainty—Which Ones Will Survive?

There were such high hopes for the electric vehicle market, which is the problem with the share prices of EV stocks today. The outlook for EVs was and is robust, but the growth was priced in at the very start.

marketbeat.com

Analyst sets Lucid stock price target

Lucid Group (NASDAQ: LCID), the luxury electric vehicle (EV) maker, has faced a tumultuous start to 2025. With its stock hovering near a year-to-date low of $2.12 as of March 6, 2025, down 2.31% pre-market and a steep 24.91% over the past month, the company has been teetering on the edge of collapse below the $2 mark.

finbold.com

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

NEW YORK , March 5, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced registered direct offering of 13,939,331 shares of common stock at a purchase price of $1.10 per share. The gross proceeds to the Company from this offering are approximately $15.3 million, before deducting the approximately $0.8 million in placement agent's fees and other offering expenses payable by the Company.

prnewswire.com

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

NEW YORK , March 4, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has entered into subscription agreements with certain accredited investors to sell 13,939,331 shares of common stock at a purchase price of $1.10 per share in a registered direct offering. The gross proceeds to the Company from this offering are expected to be approximately $15.3 million, before deducting the approximately $0.8 million in placement agent's fees and other offering expenses payable by the Company.

prnewswire.com

Wall Street sets Lucid stock price for next 12 months

Leadership turmoil at Lucid Group (NASDAQ: LCID) has sent its stock tumbling, though Wall Street remains cautiously optimistic.

finbold.com

Lucid Stock Collapses On Heavy Volume

Shares of EV company Lucid Motors (NASDAQ: LCID) have collapsed 24% in the last five trading days.

247wallst.com

Why Lucid Stock Plunged Over 25% This Week

It's been an eventful week for investors in Lucid Group (LCID -1.12%). The electric vehicle (EV) stock was already tanking ahead of earnings after getting a massive analyst downgrade when it dealt a big blow to investor confidence by announcing its CEO's sudden departure.

fool.com

Lucid Q4: CEO Resigns And Cash Burn Increases

Lucid's Q4 results showed better-than-expected revenue growth and a smaller-than-expected loss, but cash burn worsened. With a forecast of 20,000 units for 2025, Lucid's long-term ambitions remain unmet, with a valuation significantly higher than industry peers. The company's financial situation is precarious, with ongoing large losses and a potential need for additional capital raises despite current liquidity.

seekingalpha.com

Lucid Group: Add To Your Watchlist After Recent Sharp Drop (Upgrade)

Lucid's stock dropped over 10% despite a strong Q4 due to CEO Peter Rawlinson's departure, raising concerns about future development delays. Lucid reported a 79% y/y increase in vehicle deliveries and a 49% y/y revenue jump, with an optimistic FY25 outlook driven by strong orders for the new Lucid Gravity SUV. Despite competition and risks, Lucid's potential to license its superior battery technology and improved financial metrics make it a stock to watch.

seekingalpha.com

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

Lucid to support study of this expanded indication for esophageal precancer testing in partnership with NIH investigators NEW YORK , Feb. 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that a consortium of prestigious academic medical centers, led by principal investigators from Case Western Reserve University (CWRU) and University Hospitals (UH), has been awarded an $8 million National Institutes of Health (NIH) R01 grant to conduct a five-year clinical study designed to evaluate esophageal precancer detection using Lucid's EsoCheck® Esophageal Cell Collection Device and EsoGuard® Esophageal DNA Test among at-risk individuals without symptoms of chronic gastroesophageal reflux disease (GERD). The study, "A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression," aims to evaluate the effectiveness of EsoCheck and EsoGuard in detecting esophageal precancer (Barrett's Esophagus or BE) to prevent esophageal cancer (EAC) within a non-GERD at-risk population.

prnewswire.com

Better EV Stock: Lucid vs. Tesla

Electric vehicles (EVs) are in rough terrain. While U.S. EV sales rose 7% last year to 1.3 million in the U.S., the Trump administration's not-so-friendly stance toward electric vehicles has spooked some investors and ignited concerns that growth among EV makers could be stifled.

fool.com

Analysts update Lucid (LCID) stock price target

Lucid Motors (NASDAQ: LCID) has continued to face headwinds since its 2021 IPO, falling short on production and delivery targets while battling mounting financial losses and stock dilution concerns.

finbold.com

Lucid: Likely Fairly Valued

Lucid Group beat Q4 estimates on the top and bottom line. Despite 71% annual delivery growth in FY 2024 and the launch of the Lucid Gravity SUV, Lucid's absolute delivery volume remains low compared to competitors. Lucid's FY 2025 guidance of 20,000 vehicle deliveries is quite strong and implies a near-doubling of deliveries year-over-year.

seekingalpha.com

Lucid Group Still a Wreck Despite Record Production and Deliveries

Despite Lucid Group (NASDAQ:LCID) driving higher after hours following its fourth-quarter earnings report that was released on Tuesday, Feb.

247wallst.com

After abrupt departure of Lucid CEO, here are the EV maker's top priorities

Shares of electric vehicle maker Lucid Group were down more than 10% Wednesday following a downgrade of the company's stock by Bank of America and the abrupt departure of CEO Peter Rawlinson. The company is in search of a new CEO, stirring uncertainty among Wall Street analysts.

cnbc.com

Lucid Stock Falls On Q4 Results, CEO Exit: Analysts See 'Surge In Demand' For Gravity SUV

Lucid Group Inc LCID analysts highlight the strengths and weaknesses of the EV company after announcing a CEO transition and fourth-quarter financial results.

benzinga.com

Why Lucid Stock Plunged Today

Lucid Group (LCID -11.69%) recently launched its new fully electric SUV, and now has told investors it plans to produce more than twice as many electric vehicles (EVs) in 2025 as it did in 2024. It also beat expectations on both the top and bottom lines in the fourth-quarter report it delivered after the close of trading Tuesday.

fool.com

At Lucid, key-person risk is a ‘reality' investors have yet to understand

The departure of Lucid CEO Peter Rawlinson is a blow to the EV maker that the market has yet to understand, one analyst said.

marketwatch.com

RIVN or LCID Stock: Which is a Better Investment After Q4 Results?

Rivian and Lucid post narrower-than-expected Q4 losses. Let's dive into their results, outlook, and fundamentals to see if either stock is worth buying now.

zacks.com

EV maker Lucid shares drop after CEO's abrupt departure

Lucid Group Inc (NASDAQ:LCID) shares plunged 9.2% on Wednesday morning following the unexpected resignation of CEO Peter Rawlinson and a subsequent downgrade by Bank of America. Rawlinson, who has led the electric vehicle (EV) manufacturer since 2019, announced his immediate departure on Tuesday.

proactiveinvestors.com

Here's why Lucid stock rallied by 10% yesterday

Despite a significant advantage when it comes to vehicle range, luxury EV maker Lucid has struggled since debuting on the stock market in mid-2021. Ever since late 2023, Lucid stock (NASDAQ: LCID) has failed to climb above a price of $5.

finbold.com

3 Auto Stocks Investors Are Watching Closely Today

The auto industry is in the spotlight today, as several major stocks react to earnings reports, strategic moves, and executive changes.

schaeffersresearch.com

Lucid Loses $3.1 Billion

The Lucid Group Inc. (NASDAQ: LCID) net loss last year was $3.1 billion.

247wallst.com

Lucid Group's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

LCID's fourth-quarter 2024 results reflect strong growth, increased deliveries and higher capital expenditures in EV innovation.

zacks.com

Lucid Group, Inc. (LCID) Q4 2024 Earnings Call Transcript

Lucid Group, Inc. (NASDAQ:LCID ) Q4 2024 Earnings Conference Call February 25, 2025 5:30 PM ET Corporate Participants Marc Winterhoff - Interim Chief Executive Officer Gagan Dhingra - Senior Vice President of Finance and Principal Accounting Officer Taoufiq Boussaid - Chief Financial Officer Conference Call Participants John Murphy - Bank of America Securities Tom Narayan - RBC Stephen Gengaro - Stifel Chris Pierce - Needham & Company Andres Sheppard - Cantor Fitzgerald Adam Jonas - Morgan Stanley James Picariello - BNP Paribas Operator Hello, and welcome to Lucid Q4 2024 Earnings Call. At this time, all participants are in a listen-only mode.

seekingalpha.com

Lucid Group (LCID) Reports Q4 Loss, Tops Revenue Estimates

Lucid Group (LCID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.29 per share a year ago.

zacks.com

Lucid CEO steps down; EV maker plans to more than double production in 2025

Lucid said Marc Winterhoff, currently the company's chief operating officer, will step in as interim CEO.

cnbc.com

Lucid's stock rallies as luxury EV maker narrows its loss

Shares of Lucid Group Inc. shot up 6% in after-hours trading Tuesday after the luxury EV maker narrowed its quarterly loss and announced a CEO change.

marketwatch.com

Lucid CEO to step down, transition to strategic technical advisor

Electric vehicle maker Lucid Group said on Tuesday its Chief Executive Officer Peter Rawlinson will step down from the role, sending the company's shares up 12% in extended trading.

reuters.com

Lucid Motors CEO Peter Rawlinson steps down

Lucid Motors is changing CEOs for the first time in nearly six years. The company announced Tuesday that Peter Rawlinson is stepping down from the CEO and CTO roles that he's held since before the company went public.

techcrunch.com

Lucid Announces Fourth Quarter and Full Year 2024 Financial Results

Produced 3,386 vehicles in Q4 and 9,029 vehicles in 2024, in line with the 2024 annual production guidance of 9,000 vehicles Delivered 3,099 vehicles in Q4 and 10,241 vehicles in 2024; up 79% compared to Q4 2023 and up 71% compared to full year 2023 Q4 revenue of $234.5 million and annual revenue of $807.8 million GAAP net loss per share of $(0.22) in Q4 and $(1.25) in full year 2024; non-GAAP net loss per share of $(0.22) in Q4 and $(1.04) in full year 2024 Ended the quarter with approximately $6.13 billion in total liquidity 2025 production guidance of approximately 20,000 vehicles Announced CEO transition; Marc Winterhoff, COO, appointed Interim CEO, Peter Rawlinson to serve as Strategic Technical Advisor to the Chairman of the Board, stepping aside from his prior roles NEWARK, Calif. , Feb. 25, 2025 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced financial results for its fourth quarter and full year ended December 31, 2024.

prnewswire.com

Lucid Announces CEO Transition

Peter Rawlinson steps aside from prior roles, transitions to Strategic Technical Advisor to the Chairman, Marc Winterhoff Appointed Interim CEO NEWARK, Calif. , Feb. 25, 2025 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced Peter Rawlinson has stepped aside from his prior roles.

prnewswire.com

Is It Time to Push Aside EV Stocks?

Subscribers to Chart of the Week received this commentary on Sunday, February 16.

schaeffersresearch.com

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has received written notification from the Listings Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As previously disclosed, the Company was notified by Nasdaq that it was not in compliance with this listing rule because it failed to maintain a minimum closing bid price of its common stock of $1.00 per share for 30 consecutive business days.

prnewswire.com

Why Lucid Stock Plunged 10% Ahead of Earnings

Shares of Lucid Group (LCID -9.80%) plunged below $3 Monday, and were down by 10% as of 2:30 p.m. ET. A significant analyst downgrade appears to have triggered the sell-off.

fool.com

Is Lucid Stock a Buy Now?

Lucid Group (LCID -5.72%) has disappointed many investors since its public debut in July 2021. The maker of luxury electric sedans went public by merging with a special purpose acquisition company (SPAC), and it opened at $25.24 on its first day.

fool.com

1 No-Brainer Electric Vehicle (EV) Stock to Buy Right Now

Every investor wants to find the next Tesla (NASDAQ: TSLA). That's easier said than done.

fool.com

Why Lucid Stock Is Sinking Today

Lucid (LCID -7.39%) stock is heading lower in Friday's trading amid a day of big sell-offs for the broader market. The electric vehicle (EV) specialist's share price was down 7.6% as of 3:40 p.m.

fool.com

Why Lucid Group (LCID) Dipped More Than Broader Market Today

Lucid Group (LCID) closed the most recent trading day at $3.31, moving -1.78% from the previous trading session.

zacks.com

RIVN or LCID: Which Stock is Better Positioned Pre-Q4 Earnings?

The electric vehicle (EV) industry is currently at crossroads. Though e-mobility is the future, President Trump's unfriendly stance on EVs, along with slower-than-expected adoption due to high pricing, presents challenges.

zacks.com

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health

LEAA Health membership-based concierge patients will now have access to EsoGuard esophageal precancer testing as part of their enhanced personalized care service on a cash-pay basis NEW YORK , Feb. 20, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has entered into its first concierge medicine contract with LEAA Health. The contract provides LEEA Health's membership-based patients access to groundbreaking esophageal precancer testing using Lucid's EsoGuard® Esophageal DNA Test.

prnewswire.com

Lucid Stock Ahead of Q4 Earnings: To Buy or Not to Buy?

Lucid Group LCID is slated to release fourth-quarter 2024 results on Feb. 25, after market close. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of 26 cents a share on revenues of $225.5 million.

zacks.com

Lucid (LCID) stock rockets to a five-month high

Lucid Motors (NASDAQ: LCID) has surged to a five-month high, trading at $3.495 on February 18, 2025, after gaining 8% on the day and an impressive 28% over the past week.

finbold.com

Is Lucid's Explosive Growth About to Hit a Speed Bump?

It's no secret that Lucid Group (LCID 2.27%) has faced its fair share of speed bumps already. The automaker has driven through increased competition, price wars, supply chain issues, recalls, and software issues -- just to name a few.

fool.com

Lucid stock forecast: LCID sends mixed signals ahead of Feb 25

Lucid Group stock price has staged a strong recovery in the past few months, helped by the recently launched Gravity vehicle and demand from bargain hunters. The LCID share price has soared by over 70% from its lowest level in November last year, pushing its market cap to near $10 billion.

invezz.com

1 Wall Street Analyst Thinks Lucid Stock Is Going to $5. Is It a Buy?

Lucid Group (LCID 1.53%) stock has continued to decline in 2025 after a nearly 30% drop in 2024. But one Wall Street analyst thinks that shares of the electric vehicle (EV) maker have fallen too far.

fool.com

Lucid Group: Buy, Sell, or Hold?

Lucid Group (LCID 1.53%) is an up-and-coming electric vehicle (EV) manufacturer with significant backing from the Saudi Arabia Public Investment Fund. The company, which focuses on luxury EVs with extended driving ranges, has drawn investor interest since its merger with a special purpose acquisition company (SPAC) three years ago.

fool.com

Lucid Group (LCID) Increases Despite Market Slip: Here's What You Need to Know

The latest trading day saw Lucid Group (LCID) settling at $3.31, representing a +1.53% change from its previous close.

zacks.com

Why Lucid Stock Popped on Friday

Lucid Group (LCID 2.86%) stock got a 3% lift through 10 a.m. ET Friday after the company announced this morning that its new Lucid Gravity Grand Touring luxury electric car is available to order in Canada, and that a slightly less expensive Lucid Gravity Touring model will go on sale later this year.

fool.com

Why Lucid stock is surging

Lucid Motors (NASDAQ: LCID) has had a bumpy ride ever since its initial public offering (IPO) back in mid-2021.

finbold.com

Lucid Gravity Now Available to Configure and Order for Customers in Canada on the Lucid Motors Website

Lucid Gravity Grand Touring starts at $134,500 1 CDN and is available to order now Lucid Gravity Touring will start at $113,500 1 CDN and is planned for late 2025 Lucid Gravity delivers an expansive interior that comfortably seats up to seven adults and offers up to nearly 3,400 litres of cargo space. Grand Touring includes a NACS charging port and is projected to have more than 720km2 of range, 400 kW fast charging, and access to the Tesla Supercharger network Lucid Gravity Grand Touring can be found now on the configurator at the Lucid website, which can be found here for English and here for French NEWARK, Calif.

prnewswire.com

Where Will Lucid Motors Stock Be in 5 Years?

While electric vehicles (EVs) still promise to transform the global automotive industry, small players like Lucid Motors (LCID 13.59%) no longer generate the same excitement they did in 2020 and 2021. Business performance has also been lackluster, with slow growth and huge losses.

fool.com

Lucid Is Skyrocketing Today. Is the EV Stock a Buy?

Lucid (LCID 13.41%) stock is posting huge gains in Thursday's trading. The electric vehicle (EV) company's share price was up 13.4% as of 3 p.m.

fool.com

Why Lucid Group Stock Is Soaring Today

Shares of Lucid Group (LCID 14.29%) were trading 13.2% higher as of 1:15 p.m. ET Thursday after having been up by as much as 15.3% earlier in the session.

fool.com

Lucid Announces Promotion of Emad Dlala to Senior Vice President of Powertrain

NEWARK, Calif. , Feb. 13, 2025 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced that Emad Dlala has been promoted to Senior Vice President of Powertrain, effective immediately.

prnewswire.com

Lucid Stock Plunges Again This Year

In addition to falling over 70% since its initial public offering, Lucid Group Inc.

247wallst.com

Analysts set Lucid (LCID) stock price target

Lucid Group (NASDAQ: LCID) just received a fresh price target from analysts at investment banking and financial advisory firm Benchmark.

finbold.com

Think Lucid Group is Expensive? This Chart Might Change Your Mind.

Lucid Group (LCID -2.08%) looks expensive on multiple metrics. Shares trade at 9.1 times sales, despite the company never reaching profitability.

fool.com

2 Top EV Stocks to Buy in February

Electric vehicle (EV) sales struggled in 2024, but not in the way you'd think. Tesla, for instance, experienced a 1% annual sales decline in 2024, its first in over a decade.

fool.com

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEW YORK , Feb. 6, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12 at the Cliff Lodge in Snowbird, UT. Shaun O'Neil, Lucid's President and Chief Operating Officer, will host one-on-one meetings throughout the conference.

prnewswire.com

One EV Truck Maker is Going to Zero, And It's Just The First Domino To fall (RIVN, LCID, NKLA)

[00:00:04] Doug McIntyre: Lee, you and I are always worried about these smaller EV companies.

247wallst.com

Why Lucid (LCID) stock is 2025's best bargain

Although electric vehicle (EV) manufacturer Lucid (NASDAQ: LCID) has faced its share of troubles in the past year, the equity could be a compelling case for 2025, given its underlying fundamentals and growth prospects.

finbold.com

Lucid Group (LCID) Advances While Market Declines: Some Information for Investors

In the closing of the recent trading day, Lucid Group (LCID) stood at $2.80, denoting a +1.45% change from the preceding trading day.

zacks.com

Where Will Lucid Be in 1 Year?

Lucid (LCID 1.47%) has been making electric vehicles for a few years and, like many EV start-ups, is working hard to build a brand, ramp up production, and carve out a niche in an increasingly competitive space.

fool.com

3 Smart EV Stocks to Buy With $1,000 Right Now

Many electric car stocks had a difficult 2024. Industrywide growth fell below initial expectations, with some EV stocks falling in value by 50% or more.

fool.com

LUCID ALERT: Bragar Eagel & Squire, P.C. is Investigating Lucid Group on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Lucid Group (NASDAQ: LCID) on behalf of long-term stockholders following a class action complaint that was filed against Lucid on April 1, 2022 with a Class Period from November 15, 2021 to August 3, 2022. Our investigation concerns whether the board of directors of Lucid have breached their fiduciary duties to the company.

globenewswire.com

AI predicts Lucid stock price for February 1, 2025

Lucid Motors (NASDAQ: LCID) has freshly announced the appointment of Taoufiq Boussaid as its new Chief Financial Officer (CFO), with his tenure set to begin on February 25, 2025.

finbold.com

EV maker Lucid names Taoufiq Boussaid as CFO

Lucid Group has named veteran finance professional Taoufiq Boussaid as its chief financial officer, the electric vehicle maker said on Tuesday, more than a year after Sherry House stepped down from the role.

reuters.com

Lucid Announces New Chief Financial Officer

NEWARK, Calif. , Jan. 28, 2025 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced the appointment of Taoufiq Boussaid as Chief Financial Officer, planned to become effective February 25, 2025.

prnewswire.com

Analyst updates Lucid stock price outlook ahead of February earnings

Lucid Motors (NASDAQ: LCID) stock hasn't experienced a truly positive streak since early 2023, and even that upswing barely lasted a month. Indeed, LCID shares are nearly 90% down since the electric vehicle (EV) maker's initial public offering (IPO) following a string of missed forecasts and lukewarm recovery efforts.

finbold.com

Lucid Gravity: Combining 450 miles EPA Range, 400 kW Fast Charging, and Access to 20,000+ Superchargers

NEWARK, Calif. , Jan. 28, 2025 /PRNewswire/ -- Lucid Group , Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced details about the Lucid Gravity's highly innovative powertrain and charging technology that set it apart as both a daily driver and a road trip vehicle, including a NACS charging port for easy and fast charging.

prnewswire.com

Better EV Stock: Lucid vs. Rivian

It's been a bumpy ride for many electric vehicle (EV) stocks over the past few years, and both Rivian Automotive (RIVN 2.24%) and Lucid Group (LCID 2.57%) have felt each jarring pothole. Rivian's shares have tumbled 79% and Lucid's have fallen 92% over the past three years.

fool.com